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1. SUMMARY 
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used in human and veterinary 
medicine because of their main properties: anti-inflammatory, analgesic and antipyretic. The use 
of these drugs has increased significantly over the world in the last decades. The widespread 
use of NSAIDs can cause serious side effects such as gastric and intestinal disturbances. The 
control of the presence of residues of NSAIDs in food of animal origin is mandatory following 
Europe legislation; for this reason analytical methods for milk and meat analysis have to be set 
up. 
In this work, a method based on the Quick, Easy, Cheap, Effective, Rugged, and Safe 
(QuEChERS) approach was developed for the determination of NSAIDs in milk samples by 
liquid chromatography-tandem mass spectrometry (LC-MS/MS) with electrospray ionization 
(ESI) using the Multiple Reaction Monitoring (MRM) mode. 
A new sample preparation method was developed, using 5% acetic acid in acetonitrile as 
extraction system and with a clean-up step by dispersive solid phase extraction (d-SPE) using 
sorbent C18. Mass spectrometric parameters and chromatographic separation were optimized. 
Two MRM transitions were monitored for each analyte in positive or negative electrospray 
mode.  
Keywords: Non-steroidal anti-inflammatory drugs,QuEChERS, Milk, Liquid chromatography-
tandem mass spectrometry,  
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2. RESUMEN 
Los antiinflamatorios no esteroideos (AINES) son ampliamente utilizados en medicina y 
veterinaria debido a sus propiedades antiinflamatorias, analgésicas y antipiréticas. El uso de 
estos medicamentos se ha incrementado significativamente en todo el mundo en las últimas 
décadas. El uso extendido de los AINES puede causar efectos secundarios, como trastornos 
intestinales o gástricos. De acuerdo con la legislación europea, es obligatorio el control de la 
presencia de residuos de AINES en alimentos de origen animal. Por este motivo se debe 
disponer de métodos  para  el análisis de AINES en distintos tipos de alimentos. 
En este trabajo, se ha desarrollado un método basado en la estrategia QuEChERS para la 
determinación de AINES en muestras de leche por cromatografía de líquidos-espectrometría de 
masas en tándem (LC-MS/MS) con ionización por electrospray (ESI). La adquisición de datos 
se ha hecho en modo Monitorización de Reacciones Múltiples (MRM). 
Las muestras se extraen con acetonitrilo con un 5% de ácido acético y se realiza una etapa 
de clean-up mediante una extracción en fase sólida dispersiva utilizando fase C18. Se han 
optimizado los parámetros de espectrometría de masas y las condiciones cromatográficas. Se 
monitorizaron dos transiciones MRM para cada analito, trabajando con ionización en modo 
positivo y negativo.  
Palabras claves: Antiinflamatorios no esteroideos, QuEChERS, Leche, Cromatografía de 
líquidos-espectrometría de masa en tándem. 
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3.INTRODUCTION 
3.1. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) 
Non-steroidal anti-inflammatory drugs (NSAIDs) are a heterogeneous group of drugs with 
quite different chemical structures and with similar effects on human and animal health. They 
can be classified into several groups depending on their chemical structure [1]: 
a) Propionic acid derivatives: Ketoprofen (KTP), Carprofen (CPF), Naproxen (NP), 
and Ibuprofen (IBU) 
 
 
   
 
 
 
 
 
 
 
 
b) Anthranilic acid derivates: Tolfenamic acid (TLF), Mefenamic acid (MF), 
Meclofenamic acid (MEC), Flufenamic acid (FLUf) and Niflumic acid (NFL) 
 
 
 
 
Ketoprofen 
Naproxen 
Carprofen 
Ibuprofen 
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c) Nicotinic acid derivates: Flunixin (FLU) and 5-hydroxyflunixin (5-FLU) 
 
 
 
 
  
 
Mefenamic acid Niflumic acid 
Flufenamic acid Tolfenamic acid 
Flunixin 5-hydroxyflunixin 
Meclofenamic acid 
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d) Pyrazolones: Phenylbutazone (PBZ) and Oxyphenylbutazone (OPB) 
 
  
 
 
 
 
 
e) Acetic acid derivates: Diclofenac (DC) 
 
 
 
 
 
 
 
f) The class of oxicams: Meloxicam (MLX) 
 
 
 
 
 
 
 
3.1.1. Use and administration           
NSAIDs are widely used in human and veterinary medicine, because their anti-
inflammatory, antipyretic and analgesic properties. The combined analgesic and anti-
Oxyphenbutazone Phenylbutazone 
Diclofenac 
Meloxicam 
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inflammatory effects of NSAIDs make them particularly useful for the symptomatic relief of 
painful and inflammatory processes, including musculoskeletal and joint disorders, such as 
rheumatoid arthritis, osteoarthritis, and the spondyloarthropathies and in peri-articular and soft-
tissue disorders [2].  
NSAIDs provide adequate analgesia to relieve inflammation and pain in short-term 
intermittent therapy or administered as single dose [2]. 
3.1.2. Mechanism of action 
Many of the effects of NSAIDs appear to be due to their inhibition of cyclooxygenases 
(COX), which are involved in the biosynthesis of prostaglandins [2]. Cyclooxygenase has 
different isoforms; the most common are cyclooxygenase-1 (COX-1) and cyclooxygenase-2 
(COX-2). COX-1 has clear physiologic functions. Its activation leads to the production of 
prostacyclin which when released by the gastric mucosa, is cytoprotective.  COX-2 is induced 
by inflammation and the presence of proinflammatory cytokines and mitogens [4]. The inhibition 
of COX-1 is associated with adverse gastro-intestinal effects, while inhibition of COX-2 is 
associated with anti-inflammatory activity. A NSAID which inhibits COX-2 selectively should 
reduce inflammation and not influence normal physiologic function and thus should cause fewer 
gastro-intestinal effects [2]. Hence, NSAIDs can be divided into two groups according to their 
inhibitory selectivity: COX non-selective inhibitors (propionic acid derivates, salicylic acid 
derivates, pyrazole derivates, nicotinic acid derivates, acetic acid derivates, anthranilic acid 
derivates and oxicam) and COX-2 selective inhibitors (Celecoxibs, Refecoxibs) [3]. Our present 
study does not include any of the COX-2 selective inhibitors. 
3.1.3 Adverse effects 
The most common side effect are gastric and intestinal disturbances. These are usually mild 
and reversible, but in some patients peptic ulcer and/or severe gastro-intestinal bleeding have 
been reported. These adverse effects may be associated with inhibition of the cyclooxygenase-
1 (COX-1) [2]. 
Moreover, there are other effects: 
 Effects on the central nervous system (CNS)    
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The most frequent CNS adverse effects are headache and hearing loss, but also 
nervousness, depression, drowsiness and insomnia. 
 Effects on the kidneys 
NSAIDs can produce different renal disorders, some of which are due to their inhibition of 
prostaglandin synthesis.  
 Hypersensitivity reactions may occur, including fever, asthma and rashes. 
 Haematological adverse effects include anemia, thrombocytopenia, neutropenia, 
eosinophilia and agranulocytosis. 
3.1.4. Legislation  
Several NSAIDs are authorized to be administered to food-producing animals. The use of 
these drugs has increased significantly over the world in the last decades. Residues of these 
pharmaceuticals in edible products may be a potential risk to consumers. For this reason, the 
European Union (EU) has established maximum residue limits (MRLs) [5] in food products of 
animal origin.  
        
Table 1. Maximum residue limits (MRLs) for NSAIDs  
 
MRLs (µg·Kg-1) 
Compound 
 
Milk 
 
Muscle 
Bovine Porcine Equidae 
5-hydroxyflunixin 40 40 
  
Flunixin 40 20 20 20 
Diclofenac 0.1 5 
 
5 
Carprofen 
 
500 
 
500 
Tolfenamic acid 50 50 
  
Meloxicam 15 20 
  
 
Furthermore, according to the Community Reference Laboratories (CRLs) guidance paper 
12/2007 [6], the recommended concentrations for NSAIDs to be monitored in the laboratory are 
the following: 
12 Guo Luo Lili 
 
Table 2. Recommended concentrations for NSAIDs according to CRLs 
Compound Matrix 
Recommended 
concentration 
Phenylbutazone 
Oxyphenylbutazone 
Muscle, Kidney, Liver, 
Plasma, Milk 
5 µg·Kg-1 
Ibuprofen 
Naproxen 
Mefenamic acid 
Muscle, Kidney, Liver, 
Plasma, Milk 
10 µg·Kg-1 
Diclofenac Milk 5 µg·Kg-1 
3.1.5. Analysis 
It is difficult to analyze NSAIDs from different classes with one single method due to their 
chemical structure, because they are very different. Table 3 shows some multi-residue methods 
for the determination of NSAIDs in milk. Sample extraction is performed with acetonitrile [7,8, 
11] or methanol [10], and a clean-up step by SPE, using NH2 [7] or C8 cartridges [10] can be 
applied, although sometimes  the clean-up step is avoided [8]. These methods allow the 
detection of NSAIDs according to MRLs, except  Diclofenac, for which there  only  very   few are 
able to quantify this NSAID in milk at the MRL. [5]  
 
Table 3. Sample preparation for determination of NSAIDs 
AINES 
Sample 
preparation 
Conditions of 
separation 
Instrumental Reference 
Ketoprofen 
Flunixin 
Mefenamic acid 
5-hyroxyflunixin 
Oxyphenbutazone 
Phenylbutazone 
Diclofenac 
Naproxen 
Tolfenamic acid 
Carpofen 
Celecoxib 
Firocoxib 
Rofecoxib 
Extraction: 
acetonitrile in 
the presence 
of ammonium 
acetate 
Clean-up: 
Sep-Pak NH2 
cartridge 
Column: 
phenomenex 
Luna C8 (3µm, 
2.1mm x 
150mm) 
 
Phase mobile: 
MeOH/ACN 8:2 
(v /v) (phase A) 
0.01 mol/L 
ammonium 
formate pH 5.0 
(phase B) 
 
Liquid 
chromatograph 
(Agilent 
Techonologies 
1200) 
connected to 
QTrap 5500 
mass 
spectrometer. 
MS: ESI+/ESI- 
Jedziniak.P 
et al. 2012 [7] 
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Ibuprofen 
Meloxicam 
Metamizolemetabolites 
Ketoprofen 
Carprofen 
Flunixin 
Mefenamic acid 
Flufenamic acid 
5-hydroxyflunixin 
Phenylbutazone 
Oxyphenbutazone 
Meclofenamic acid 
Diclofenac 
Niflumic acid 
Tolfenamic acid 
Meloxicam 
4-
methylaminoantipyrine 
Extraction: 
ACN 
No Clean-up 
Column:  
Waters 
symmetry C18 
(5µm, 2.1 x 150 
mm) 
 
Phase mobile: 
Water/ACN 
(95/5) and 0.1% 
formic acid 
(phase A) 
0.1% formic 
acid and ACN 
(phase B) 
Acquity UPLC 
system 
connected to 
MicroMass 
Quattro Ultima  
triple 
quadrupole 
E.Daeseleire 
et al. [8] 
Naproxen 
Carprofen 
5-hydroxyflunixin 
Flunixin 
Mefenamic acid 
Flufenamic acid 
Phenylbutazone 
Oxyphenbutzaone 
Meclofenamic acid 
Niflumic acid 
Tolfenamic acid 
Ketorprofen 
Suxibuzone 
Flurbiprofen 
Extraction: 
ACN/MeOH + 
ascorbic acid 
buffer 0.01M 
and HCl 1.0M 
 
Clean-up: 
SPE cartridge 
Column:  Max 
RP Synergi 
stainless steel 
(Phenomenex) 
 
Phase mobile: 
0.1% acetic acid 
in water (phase 
A) 
0.1% acetic acid 
in ACN (phase 
B) 
 
Agilent 1200 
system 
connected to 
QTRAP 4000 
mass 
spectrometer 
Gallo P et al. 
[9] 
Mefenamic acid 
Flufenamic acid 
Phenylbutazone 
Extraction: 
MeOH + HCl 
0.24M and 
ascorbic acid 
Column:Acquity 
UPLC® HSS T3 
C18 (1.8µm, 50 
Waters® LC-
MS/MS system 
The 
Laboratory of 
Public Health 
Agency in 
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Oxyphenbutazone 
Meclofenamic acid 
Carboxiibuprofen 
Piroxicam 
Naproxen 
Niflumic acid 
Flurbiprofen 
Indometacin 
Suxibuzone 
0.02M 
 
Clean-up: 
SPE C8 
cartridge 
x 2.1 mm) 
 
Phase mobile: 
formic acid 
0.1% pH =4 
(phase A) 
0.1% formic 
acid in ACN 
(phase B) 
 
 
Valencia [10] 
Flunixin 
Phenylbutazone 
 
Extraction: 1% 
acetic acid in 
ACN + 
sodium 
acetate 
+MgSO4 
 
No clean-up 
Column 
phenomenex, 
Biphenyl, 
kinetex, 2.6µm, 
100mm x 
2.1mm 
 
Phase mobile: 
0.1% formic 
acid (phase A) 
10 mM 
ammonium 
acetate in water 
(phase B) 
Waters Acquity 
UPLC coupled 
with a Q-TOF 
Premier 
Wang. J et al. 
2012 [11] 
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4. OBJECTIVES 
The final aim of this work is to develop a method for the analysis of 15 NSAIDs in milk 
samples by LC-MS/MS according to the legal requirements. 
The objectives are: 
 Optimization of mass spectrometry conditions to achieve two suitable multiple 
reaction monitoring (MRM) transitions for each NSAID. 
 Optimization of liquid chromatographic separation  
 Set up of a simple multi-residue extraction method of NSAIDs from milk samples.  
5. EXPERIMENTAL SECTION 
5.1. REAGENTS 
5.1.1. NSAIDs standards and internal standards  
Ketoprofen (KTP)  
Carprofen (CPF)  
Naproxen (NP)  
Ibuprofen (IBU) 
Tolfenamic acid (TLF) 
Mefenamic acid (MF) 
Meclofenamic acid (MEC) 
Niflumic acid (NFL) 
Flufenmic acid (FLUF) 
Flunixin (FLU) 
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5-hydroxyflunixin (5-FLU) 
Phenylbutazone (PBZ) 
Oxyphenbutazone (OPB) 
Diclofenac (DC)   
Meloxicam (MLX) 
All were over 98% purity and provide by Sigma Aldrich. 
 
Meloxicam-D3 
Niflumic acid 13C6  
Flufenamic acid 13C6  
Phenylbutazone13C6 
All were over 98% purity and provide by Sigma Aldrich 
5.1.2. Other  chemicals 
Acetonitrile 
Acetic acid  
Ammonium acetate 
Na2SO4 
 Ascorbic acid 
HCl 
MgSO4 and   
Formic acid   
Sorbent C18   
All were analytical reagent grade 
Water was obtained with a Milli-Q system 
5.2. PREPARATION OF  STANDARD SOLUTIONS 
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The individual stock standard solutions were prepared in methanol at concentration of 1000 
mg·L-1 for each of the 15 NSAID standards. The mixed standard solutions were prepared by 
dilution of the individual standard solutions at concentration of 20 mg·L-1, working standard 
solutions (0.4 mg·L-1, 2.0 mg·L-1 and 5.0 mg·L-1) were prepared in 0.1% formic acid by dilution 
of the mixed standard solution of 20 mg·L-1. All standard solutions were stored at -20 ºC and 
were stable at least for 6 months. 
The mixed internal standard solution (IS), including Meloxicam-D3, Niflumic acid 13C6, 
Flufenamic acid 13C6 and Phenylbutazone13C6, was prepared in 0.1% formic acid at 
concentration 20 mg·L-1. It was stored at -20 ºC and was stable at least for 6 months. 
5.3.  INSTRUMENTATION 
5.3.1. Liquid chromatography-tandem mass spectrometry (LC-MS/MS)  
5.3.1.1. Waters Acquity-QqQ Premier 
The system consisted of Waters Acquity UPLC coupled to Quattro Premier QqQ mass 
spectrometer  and separations were achieved using a Phenomenex Kinetex C18 column 
(1.8µm, 100mm x 2.1mm); the column temperature was kept at 40ºC. Chromatographic 
separation was carried out  using a mobile phase consisting of 0.1% formic acid (phase A) and 
0.1% formic acid in ACN (phase B) at a flow rate of 0.4 ml·min-1, with the gradient program 
shown in  Figure 1. The injection volume was 10 µl. The total runtime, including equilibration,  
was 14 min. 
 
Figure1. Gradient conditions used for LC separation with the Waters system 
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The MS/MS detection was performed with electrospray ionization in positive mode and 
using the multiple reactions monitoring (MRM) mode. Two transitions for compound were 
monitored and one transition for the internal standards. Table 4 shows the MS parameters for 
each compound. 
 
Table 4. MS/MS parameters for  NSAIDs detection with Quattro Premier QqQ mass spectrometer 
 
Precursor ion 
(m/z) 
CV 
(V) 
Product ion 
1 (m/z) 
CE 
(V) 
Product ion 
2 (m/z) 
CE 
(v) 
Fluninxin 297 35 279 20 265 35 
Ketoprofen 255 30 105 25 209 15 
Diclofenac 296 20 250 13 278 9 
Flufenamic acid 282 23 244 27 264 19 
5-hydroxyflunixin 313 35 280 30 295 25 
Niflumic acid 283 36 245 28 265 22 
Naproxen 231 20 170 25 185 15 
Meloxicam 352 29 141 25 115 15 
Carprofen 274 15 193 33 228 20 
Phenylbutazone 309 30 120 20 211 16 
Mefenamic acid 242 23 209 28 242 15 
Tolfenamic acid 262 23 209 28 244 15 
Oxyphenbutazone 325 25 148 28 204 16 
Meclofenamic 
acid 
296 21 243 24 278 12 
(a) CV: Cone  voltage 
(b) CE: Collision energy 
 
5.3.1.2. Agilent Technologies 1290-QqQ 6460 
The LC system consisted of an Agilent Technologies 1290 connected to a Triple 
Quadrupole (QqQ) 6460 with electrospray ionization (ESI). A gradient LC system (Figure 2) 
using 0.1% formic acid (mobile phase A1) and acetonitrile (mobile phase B1) at a flow rate of 
0.4 ml·min-1 were used to separate the NSAIDs on a column Phenomenex Kinetex Biphenyl 
(2.6µm, 100 x 2.1mm). The column temperature was kept at 40ºC and the injection volume was 
20 µl. The total runtime, including equilibration, was 14 min. 
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Figure 2. Gradient conditions used for LC separation with the Agilent equipment 
The MS/MS detection was performed with electrospray ionization operated in both positive 
and negative polarities using the multiple reactions monitoring (MRM) mode. Two transitions for 
compound were monitored and one transition for the internal standards. Table 5 shows the 
MS/MS parameters for each compound.  
 
Table 5. MS/MS parameters for  NSAIDs detection with Agilent QqQ 6460 mass spectrometer 
 
ESI+/ESI
- 
Precursor 
ion (m/z) 
Fragmentor 
energy (V) 
Product 
ion 1 
(m/z) 
CE  
(V) 
Product 
ion 2 
(m/z) 
CE 
(V) 
5-hydroxyflunixin ESI+ 313 110 295 25 280 35 
Diclofenac ESI- 294 90 250 10   
Phenylbutazone ESI- 307 130 279 15 131 15 
Flunixin ESI- 295 70 251 15 209 35 
Flufenamic acid ESI- 281 130 237 15 216 25 
Ketoprofen ESI+ 255 130 105 15 77 50 
Meclofenamic 
acid 
ESI+ 297 110 279 15 264 40 
Mefenamic acid ESI- 240 70 196 20   
Naproxen ESI- 229 160 185 50 169 35 
Niflumic acid ESI- 281 130 237 15 177 35 
Oxyphenbutazone ESI- 323 130 295 15 134 15 
Carprofen ESI- 271 130 228 5 226 25 
Tolfenamic acid ESI- 260 110 216 5   
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Ibuprofen ESI- 205 110 161 1   
Meloxicam ESI+ 352 130 141 15 115 25 
(a) CE: Collision energy 
5.3.2. Other equipment 
A multi-tube vortex (VWR, DVX-2500), laboratory centrifuge (Rotanta 460R), vertical 
agitator (Agitax) and nitrogen evaporator (Turbo Vap) were used for sample preparation.  
5.4.  SAMPLE  PREPARATION 
5.4.1. Extraction  
5 g of milk were weighed in a centrifuge tube. Next, 10ml of 5% acetic acid in ACN, 1g of 
ammonium acetate and 5g of Na2SO4 were added. The sample was shaken for 5 minutes and it 
was centrifuged (3000rpm, 10ºC, 10min). Then, the supernatant was transferred to a centrifuge 
tube containing 150mg of sorbent C18 and 1g of MgSO4. 4ml of ascorbic acid 0.02M and HCl 
0.24M and 2 g of Na2SO4 were added. The mixture was shaken for 4 min and it was centrifuged 
again under the same conditions. Then, the supernatant was evaporated to 250µl (N2, 40ºC). 
Finally, the residue was re-dissolved in 250µl of 0.1 % formic acid filtered through a 0.22µm 
nylon filter membrane. 
5.4.2. Calibration 
The quantification of NSAIDs in milk samples was based on the use of surrogate matrix 
matched standards (SMMS), which consists of blank milk samples spiked with known amount of 
NSAIDs and submitted to the whole sample treatment procedure. Calibration with SMMS allows 
overcoming matrix effects on mass spectrometry detection. In this work, three working 
standards solutions (0.4 mg·L-1, 2 mg·L-1 and 5 mg·L-1) were added to spike blank  samples at 
four levels (Table 6) to prepare surrogate matrix method standards. 
 
Table 6. Spiking level (µg·Kg-1) for determination of NSAIDs in milk. 
 
Concentration (µg·Kg -1) Blank milk (g) IS (µl) Standard solution (µl) 
ME1 2.5 5 100 31.3 (0.4 mg·L-1) 
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ME2 5 5 100 12.5 (2 mg·L-1) 
ME3 10 5 100 25 (2 mg·L-1) 
ME4 25 5 100 25 (5 mg·L-1) 
6. RESULTS AND DISCUSSION  
6.1.  MASS SPECTROMETRY DETECTION 
According to UE decision 657 [12], for a confirmatory method based on LC-MS/MS, the 
acquisition of two transitions is required. Therefore, two transitions for compound were 
monitored, the most sensitive transition was selected for quantification and the other was used 
for confirmation. Only one transition was monitored for the internal standards.  
6.1.1. Preliminary study 
In the beginning of this work, some preliminary experiments were performed with the Waters 
Acquity-Quattro Premier QqQ LC-MS equipment with the electrospray ionization in positive 
mode. 
First of all, cone voltage for the precursor ion has to be optimized. Afterwards, product ions 
should be selected and the corresponding collision energy optimized. 
The optimization consisted of the direct infusion of the individual standard solution of NSAID 
at 2 mg·L-1 with the following conditions: 
• Mobile phase: 0.1% formic acid (phase A) and 0.1% formic acid in ACN(phase B)  
• Mass spectrometry: MS Scan mode was used to optimize precursor ion and cone 
voltage, MS daughter Scan mode was used to optimize product ions and collision energies. 
As an example, in the following figures the optimized precursor ion and product ions for 
Ketoprofen are shown:   
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Figure 3. Precursor ion of Ketoprofen (m/z= 255) 
 
 
Figure 4. Product ion 1 of Ketoprofen (m/z= 105) 
Precursor ion  
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Figure 5. Product ion 2 of Ketoprofen (m/z =209) 
Some NSAIDs were not detected in positive ion mode. Since with  the Waters instrument it 
was not possible to detect compounds in negative polarity, further experiments were performed 
with the Agilent Technology 1290 infinity-QqQ 6460 Instrument. 
6.1.2. Optimization of mass spectrometry detection 
In order to achieve the optimum MS/MS conditions for NSAIDs detection, fragmentor energy 
and collision energies for each individual compound were optimized using the Agilent 
Technologies 1290 -QqQ 6460. 
The optimization was performed using electrospray ionization operated in both positive and 
negative polarities. It is consisted of the injection of the NSAIDs mixture standard solution at 0.4 
mg·L-1  in the LC- MS/MS system with the following conditions: 
 Column: Phenomenex Kinetex C18, (1.8µm, 100mm x 2.1mm) 
 Mobile phase: water (phase A) and ACN (phase B)  
 Mass spectrometry: precursor ion Scan or product ion Scan modes with positive 
and negative ionization. 
6.1.2.1. Precursor ions 
The optimization of precursor ion was performed using precursor ion SCAN mode with 
different fragmentor energies (70V, 90V, 110V, 130V) for each NSAIDs. Intensities of different 
Product ion 2 
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fragmentor energies were compared, and the voltage that provided the highest response was 
selected.  
As an example, figure 6 shows a mass spectra obtained in the optimization process of the 
fragmentor energy for the  precursor ion of Meloxicam (m/z=352), and the highest response was 
obtained with 130V. 
 
 
Figure 6. Mass spectra of the optimization process of the fragmentor energy for the precursor ion of 
Meloxicam (m/z =352) (70V-90V-110V-130V) 
6.1.2.2. Product ions 
After optimization of the fragmentor energy, the mass spectrometer was operated in product 
ion SCAN mode to optimize the detection of product ions with different collision energies (5V, 
15V, 25V, 35V, 40V, 45V, 50V). Then intensities obtained for the product ions at different 
collision energies were compared, and the collision energy that provided the highest response 
was selected. Two transitions were monitored for each compound, the most sensitive transition 
was selected for quantification and the other was used for confirmation. Only one transition was 
monitored for the internal standards.  
Figures 7 and 8 show mass spectra of the optimization process of the collision energy for 
product ions of Meloxicam (m/z=141 and m/z = 115) and the highest response was obtained 
with 15V and 25V 
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Figure 7. Mass spectra of the optimization process of the collision energy for the product ion 1 of 
Meloxicam (m/z = 141) (5V-15V-25V-35V) 
 
 
Figure 8. Mass spectra of the optimization process of the collision energy for the product ion 2 of 
Meloxicam (m/z =115) (5V-15V-25V-35V) 
 
Most NSAIDs were ionized in the negative ion mode with acceptable sensitivity and low 
baseline noise, but for some compounds (Ibuprofen, Tolfenamic acid, Diclofenac and 
Mefenamic acid) only one product ion was obtained. Positive ionization was finally selected for 
5-hydroxyflunixin, Ketoprofen, Meclofenamic acid and Meloxicam. 
The optimized MS conditions for NSAIDs detection are summarized in Table 7. 
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Table 7. MS/MS parameters for NSAIDs detection 
 ESI+/ESI- 
Precursor 
ion (m/z) 
Fragmentor 
energy (V) 
Product 
ion 1 
(m/z) 
CE  
(V) 
Product 
ion 2 
(m/z) 
CE 
(V) 
5-hydroxyflunixin ESI+ 313 110 295 25 280 35 
Diclofenac ESI- 294 90 250 10   
Phenylbutazone ESI- 307 130 279 15 131 15 
Flunixin ESI- 295 70 251 15 209 35 
Flufenamic acid ESI- 281 130 237 15 216 25 
Ketoprofen ESI+ 255 130 105 15 77 50 
Meclofenamic 
acid 
ESI+ 297 110 279 15 264 40 
Mefenamic acid ESI- 240 70 196 20   
Naproxen ESI- 229 160 185 50 169 35 
Niflumic acid ESI- 281 130 237 15 177 35 
Oxyphenbutazone ESI- 323 130 295 15 134 15 
Carprofen ESI- 271 130 228 5 226 25 
Tolfenamic acid ESI- 260 110 216 5   
Ibuprofen ESI- 205 110 161 1   
Meloxicam ESI+ 352 130 141 15 115 25 
 (a) CE: Collision energy 
 
6.2.  CHROMATOGRAPHIC  SEPARATION OPTIMIZATION 
The selection of column and gradient conditions affects peak shape, retention time and 
sensitivity. In this work, different gradient conditions and different columns were tested. 
First experiments were performed with a Phenomenex Kinetex C18 column (1.8µm, 100mm 
x 2.1mm) and different gradient conditions were compared to achieve the optimum conditions 
for chromatography separations. The optimization consisted of the injection in the LC- MS/MS 
system of the standard mixture solution at 0.4 mg·L-1 and mobile phases were based on  water 
(phase A) and ACN (phase B).  
 
Table 8. Gradient conditions 1 
Time (min) %A %B 
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0.00 80 20 
2.00 80 20 
10.00 45 55 
10.10 80 20 
14.00 80 20 
 
 
 
Figure 9. Chromatogram (MRM) of NSAIDs in standard solution (0.4 mg·L-1) with gradient conditions 1. 
 
Table 9. Gradient conditions 2. 
Time (min) %A %B 
0.00 80 20 
2.00 80 20 
12.00 45 55 
12.10 80 20 
20.00 80 20 
 
 
Figure 10.  Chromatogram (MRM) of NSAIDs in standard solution (0.4 mg·L-1) with gradient conditions 2. 
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With the both gradient 1 and 2, broad peaks were obtained and this reduced the sensitivity 
due to reduced peak height (Figure 9 and 10). Different gradient time did not improve 
chromatographic separation. 
 
 
Figure11. Gradient conditions 
Then, the initial percentage of organic solvent (phase B) was reduced (gradient 3), elution 
times were delayed. Because NSAIDs are soluble in the organic solvent, a reduction of the 
percentage of organic solvent improved the retention of compounds in the stationary phase, on 
the contrary, when the percentage of organic solvent increases, the elution of NSAIDs is speed 
up.  Moreover, elution times were delayed due to the initial isocratic conditions. 
 
Table 10. Gradient conditions 3 
Time (min) %A %B 
0.00 90 10 
2.00 90 10 
10.00 45 55 
10.10 90 10 
14.00 90 10 
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Determination of Non-steroidal anti-inflammatory drugs in milk by liquid chromatography-tandem mass spectrometry 29 
 
 
 
Figure 12. Chromatogram (MRM) of NSAIDs in standard solution (0.4 mg·L-1) with gradient conditions 3. 
Elution conditions without the initial isocratic zone were tested (Gradient 4) and retention 
times decreased.  
 
Table 11. Gradient conditions 4 
Time (min) %A %B 
0.00 90 10 
10.00 45 55 
10.10 90 10 
14.00 90 10 
 
 
Figure 13. Chromatogram (MRM) of NSAIDs in working standard solution (0.4 mg·L-1) with gradient 
conditions 4. 
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Figure 14. Gradient conditions  
 
In all the assayed conditions, the chromatographic peaks obtained with the Kinetx C18 
column were quite broad, and some experiments were performed with a Phenomenex biphenyl 
column  (2.6µm, 100mm x 2.1mm) and peaks were narrower than those obtained previously 
with the kinetex C18 column (Figure 15) 
 
 
Figure 15. Chromatogram (MRM) of NSAIDs in standard solution (0.4 mg·L-1) using Phenomenex Biphenyl 
column 
With Phenomenex biphenyl column, when compared to the kinetex C18 column, there is a 
change of selectivity; the analytes interact with the stationary phase due to formation of π-π 
bonds between aromatic groups of NSAIDs and stationary phase. The elution order of the 
analytes changed, because of different column selectivity. 
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The narrower peaks in biphenyl column, leads to an improved sensitivity, which is 
advantageous for the detection of very low concentration levels of NSAIDs. 
 
 
Figure16. Comparison of MRM chromatograms from Phenomenex Kinetex C18 column (black) and 
Phenomenex Biphenyl column (red) 
When extracts from milk samples containing NSAIDs were injected into the Biphenyl column 
and gradient 4, based on water and ACN was applied,  splitted peaks were obtained for some 
analytes,  as can be observed in figure 17, probably due to the dissociation equilibrium. For this 
reason, water containing  0.1% formic acid and ACN were selected as mobile phases. In this 
acid conditions, the analytes had only one single form (protonated), and the peak shape 
improved (Figure 18). Moreover, formic acid improves the ionization of NSAIDs and baseline 
noise was reduced. 
 
Figure 17. Ion chromatogram (transition used for quantification) of 5-hydoxyflunixin using water/ACN as 
mobile phase 
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Figure 18. Ion chromatogram (transition used for quantification) of 5-hydoxyflunixin using 0.1% formic acid 
/ACN as mobile phase 
Figure 19 shows a chromatogram of a mixture of NSAIDs (0.4 mg·L-1)  obtained in the 
selected conditions: biphenyl column, water containing 0.1% formic acid and acetonitrile as 
mobile phases and gradient 4. 
 
 
Figure 19. Chromatogram  of NSAIDs in standard solution 0.4 mg·L-1  using 0.1% formic acid and ACN  as 
mobile phase and Phenomenex biphenyl column 
 
6.3. SAMPLE  PREPARATION 
Several methods for the analysis of NSAIDs in milk samples have been published (Table 3), 
and two of them were tested in this work. Briefly, the procedures assayed in this work were: 
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1) Extraction with ACN and clean-up by SPE using NH2 cartridge 
This procedure was  published by Jedziniak.P et al, [7]:  
1. 10 g of milk were weighed in a polypropylene centrifuge tube.  
2. The sample was mixed (vortex) and left for 10min. 
3. 10 ml ACN and 2g ammonium acetate were added and centrifuged (3000g, 
10min, 10ºC) 
4. The supernatant was cleaned-up on a Sep-Pak NH2 cartridge: 
4.1. 2 g sodium sulfate were added into the cartridge (an additional layer) 
4.2. The cartridge was preconditioned with 5 ml ACN  
4.3. Analytes were eluted with 6ml of 5% formic acid in ACN. 
5. The extract was evaporated to 250 µl (N2, 40ºC) 
6. The residue was re-dissolved with 250 µl  water. 
7. The sample was transferred into a vial with filter. 
Blank samples for calibration were spiked in the concentration range between 1-10 µg·Kg-1.  
2)  Extraction with methanol and clean-up by SPE using  C8 cartridge 
The method was developed by the Laboratory of Public Health Agency in Valencia [10]:  
1. 2.5 g of milk were weighed in a polypropylene centrifuge tube.  
2. 6 ml MeOH were added, the sample was mixed for 10min, then centrifuged 
(11000rpm, 5min, 10ºC). 
3. The supernatant was evaporated to 2ml (N2, 50ºC). 
4. 4ml solution of HCl 0.24M and ascorbic acid 0.02M were added to the sample. 
5. The extract was cleaned on C8 cartridge : 
5.1. The cartridge was preconditioned with 4 ml MeOH and 4ml  solution of HCl 
0.24M and ascorbic acid 0.02M 
5.2. The extract loaded into the cartridge. 
5.3. The cartridge was washed with 4ml MeOH/water (30:70) 
5.4. The cartridge was dried under vacuum for 15min 
5.5. Analytes were eluted with 4ml ethyl acetate. 
6. The eluate was evaporated to dryness (N2, 50ºC) 
7. The extract was re-dissolved with 250µl mixture of 0.1% formic acid (pH=4) and 
ACN (50/50). 
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Blank samples for calibration were spiked in the concentration range between 1-10 µg·Kg-1. 
The figure 20 shows responses obtained with both sample preparation methods. As it can 
be observed, the procedure based on extraction with ACN and clean-up by SPE using NH2 
cartridges  gave higher responses.  
 
 
Figure 20. Areas of NSAIDs in milk fortified at 1 µg·Kg-1  analyzed with different solid-phase extraction 
cartridges. 
Then, a procedure based on extraction with MeOH and clean-up by SPE using C18 was 
tested. Compared to the procedure  using C8 cartridges, similar responses were obtained. On 
the basis of these results, it was concluded that, among the assayed methods, the best results 
were achieved with the method based on acetonitrile and amine cartridges. 
6.3.1.  QuEChERS methodology  
Because of its simplicity and convenience, the Quick, Easy, Cheap, Effective, Rugged, and 
Safe (QuEChERS) approach was investigated.  
No references were found in the literature about the application of  QuEChERS strategies to 
analysis of NSAIDs in milk. The procedure initially applied was the following: 
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1. 5 g of milk were weighed in a centrifuge tube. Next, 10 ml of 5% acetic acid in ACN, 1g 
of NaCl and 5g of Na2SO4 were added. 
2. The tube was shaken for 5 minutes (vortex). Then it was centrifuged (4000 rpm, 10ºC, 
10min). 
3. The supernatant was transferred into a centrifuge tube containing 150mg of sorbent 
C18 and 1g MgSO4 (Agilent QuEChERS kits), the tube was shaken for 4 min (vortex). 
4. The mixture was centrifuged again under the same conditions. 
5. The supernatant was evaporated to 250µl (N2, 40ºC). 
6. The residue was re-dissolved in 250µl of 0.1% formic acid, filtered through a 0.22µm 
nylon filter membrane. 
Responses of QuEChERS and NH2-SPE methods were compared (Figure 21). 
Meclofenamic acid and 5-hydroxyflunixin gave higher response with NH2-SPE method, but other 
NSAIDs gave higher responses with the QuEChERS method. Moreover, the QuEChERS 
method is easier and more effective method. So the QuEChERS approach was further 
investigated for the sample extraction. 
 
 
Figure 21. Area of NSAIDs in milk fortified at 1 µg·Kg-1 analyzed with different methods 
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6.3.1.1. QuEChERS methodology optimization 
The QuEChERS method was optimized in this work. Initially, the clean-up was performed  
using commercial sorbent C18 and salts supplied in tubes (Agilent QuEChERS kits), but during 
agitation, samples were not homogenized properly because centrifuge tubes were small (1.5 cm 
diameter), For this reason, “in house” preparation with large centrifuge tube (2.5 cm diameter) 
was tested in the  clean-up step, and NSAIDs responses improved.  
 
 
Figure 22. Agilent QuEChERS kits (left) and laboratory centrifuge tube (right) 
 
Then, acetonitrile extraction with no clean-up step was compared with the QuEChERS 
method with the  clean-up procedure using sorbent C18 (Figure 23). It can be observed that 
clean-up is a critical step in the sample preparation. The procedure without clean-up detected 
fewer analytes and provided lower response. 
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Figure 23. Area of NSAIDs in milk fortified at 1µg·Kg-1 
In a further step the primary secondary amines (PSA) sorbent was used in the dispersive 
solid-phase extraction (d-SPE) step, but in general results were worse than those obtained with 
C18 sorbent (Figure 24), except for Meclofenamic acid and Meloxicam. 
 
 
Figure  24. Area of NSAIDs in milk fortified at 2.5 µg·Kg-1 analyzed with Quechers method using different 
sorbent. 
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In all the assayed conditions the peak area for Phenylbutazone and Oxyphenbutazone was 
very low. According to some authors [1,9,10], the addition of ascorbic acid in the clean-up step 
avoids oxidation of Phenylbutazone and it was investigated. Extraction procedure was the 
following: 
1. 5g of the milk were weighed in a centrifuge tube. Next, 10 ml of 5% acetic acid in 
ACN, 1g of NaCl and 5g of Na2SO4 were added. 
2. The tube was shaken for 5 minutes (vortex). Then was centrifuged (3000rpm, 10ºC, 
10min). 
3. The supernatant was transferred to a centrifuge tube containing 150mg of sorbent C18 
and 1g of  MgSO4.  
4. 4ml of ascorbic acid 0.02M and HCl 0.24M were added.  
5. The mixture was shaken for 4 min (vortex) and it was centrifuged again under the 
same conditions. 
6. The supernatant was evaporated to 250 µl (N2, 40ºC). 
7. The residue was re-dissolved in 250µl of 0.1% formic acid, filtered through a 0.22µm 
nylon filter membrane.  
The addition of ascorbic acid improved the signal of Phenylbutazone and Oxyphenbutazone 
(Figure 25), but the sensitivity for Diclofenac, Tolfenamic acid and Mefenamic acid decreased, 
but were still detected in the low µg·Kg-1 range. We decided to use ascorbic acid because 
Phenylbutzone and Oxyphenbutazone are important analytes to determine after the scandal of 
the horse meat in UK.  
 
a)  
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b)  
 
 
Figure 25. Ion chromatograms (transitions used for quantification) of Phenylbutazone (a) and  
Oxyphenbutazone (b) 
 
According to Jedziniak.P et al [7], ammonium acetate is more suitable than NaCl in the 
extraction step, because NaCl can promote formation of sodium adducts and reduce sensitivity 
in MS detection (Figure 26.a). Therefore we tested the addition of ammonium acetate and as a 
result the response of NSAIDs and baseline noise improved (Figure 26.b). 
 
a)  
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b)  
 
Figure 26. Ion chromatograms (transitions for quantification) of Ketoprofen using NaCl (a) and  ammonium 
acetate (b) 
Evaporation was a long step (2h approximate). The addition of anhydrous Na2SO4 to the 
organic extract allowed to reduce the evaporation time (about 1h) while similar responses were 
obtained. 
Finally, the QuEChERS method  using sorbent C18  was selected for the sample preparation. 
In the procedure, the sample is extracted with acetonitrile under the acidic conditions for protein 
precipitation, and ammonium acetate is added before ensured separation of organic and water 
phase in the extraction. Then, Na2SO4 is added to the organic phase to remove water. The 
addition of ascorbic acid before d-SPE step avoids to the oxidation of Phenylbutazone and 
Oxyphenbutazone. 
Summarizing, the optimized QuEChERS method  procedure was the following: 
1. 5g of milk were weighed in a centrifuge tube. Next, 10 ml of 5% acetic acid in 
ACN, 1g of ammonium acetate and 5g of Na2SO4 were added. 
2. The tube was shaken for 5 minutes (vortex). Then, it was centrifuged (3000rpm, 
10ºC, 10min). 
3. The supernatant was transferred to a centrifuge tube containing 150mg of sorbent 
C18 and 1g of MgSO4. 
4. 4ml of ascorbic acid 0.02M and HCl 0.24M and 2g of Na2SO4 were added.  
5. The mixture was shaken for 4 minutes, then it was centrifuged again under the 
same conditions. 
6. The supernatant was evaporated to 250µl (N2, 40ºC). 
Determination of Non-steroidal anti-inflammatory drugs in milk by liquid chromatography-tandem mass spectrometry 41 
 
7. The residue was re-dissolved in 250µl of 0.1% formic acid, filtered through a 
0.22µm nylon filter membrane.  
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7. CONCLUSIONS 
1. Mass spectrometry with ESI in positive and negative modes allows the sensitive 
detection of NSAIDs, in the low µg kg-1 range. 
2. Phenomenex biphenyl column (2.6µm, 100mm x 2.1mm) is suitable for the 
separation  of NSAIDs, using 0.1% formic and ACN as mobile phase.  
3. The QuEChERS methodology is a suitable approach for the extraction of NSAIDs 
from milk samples, but optimization is required. The QuEChERS and LC-MS/MS  
method allows the confirmatory analysis of 5-hydroxyflunixin, Flunixin, 
Phenylbutazone, Flufenamic acid, Ketoprofen, Meclofenamic acid, Niflumic acid, 
Oxyphenbutazone, Carprofen and Meloxicam according to the legal limits.  
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9. ACRONYMS 
NSAIDs: Non-steroidal anti-inflammatory drugs  
QuEChERS: Quick, Easy, Cheap, Effective, Rugged and Safe 
MRM: Multiple reaction monitoring 
ESI: Electrspray ionization 
d-SPE: Dispersive solid-phase extraction 
KTP: ketoprofen 
CPF: Carprofen 
NP: Naproxen 
IBU: Ibuprofen 
TLF: Tolfenamic acid 
MF: Mefenamic acid 
MEC: Meclofenamic acid 
NFL: Niflumic acid 
FLUF: Flufenamic acid 
FLU: Flunixin 
5-FLU: 5-hydroxyflunixin 
PBZ: Phenylbutazone 
OPB: Oxyphenbutazone 
DC: Diclofenac 
MLX: Meloxicam  
COX-1: Cyclooxygenase-1 
COX-2: Cyclooxygenase-2 
CNS: Central nervous system  
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MRLs: Maximum residue limits 
CRLs: Community reference laboratories 
ACN: acetonitrile 
MeOH: methanol  
IS: Internal standard solution  
CV:  cone voltage 
CE: collision energy 
PSA: primary secondary amines 
SPE: solid-phase extraction  
 
 
 
  
